A post-marketing surveillance, multicenter trial to study saroglitazar in patients with diabetic dyslipidemia.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2015
At a glance
- Drugs Saroglitazar (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions; Therapeutic Use
- 28 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.